The study was led by Pierre Weiss and colleagues at the University of Nantes.
Here are four things to know:
1. Injectable calcium phosphate cements have been around for nearly a hundred years, and are frequently used in orthopedics and traumatology as bone substitutes during surgery.
2. The researchers applied a sophisticated hydrogen as a foaming agent to create air bubbles in the mixture, creating an effective macroporous, self-setting CPC.
3. The key to the breakthrough was in applying a silanized hydrogel as a foaming agent.
4. Follow-up tests showed that new bone did form at the implant sites with no toxic effects.
More articles on orthopedics:
Arryo Grande has highest rate of hip mortality — 5 takeaways
Dr. William Bennett internationally recognized — 5 highlights
FDA halts US marketing of Materialise X-Ray Knee Guide — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
